SG Americas Securities LLC Trims Stake in Solventum Co. (NYSE:SOLV)

SG Americas Securities LLC lessened its position in shares of Solventum Co. (NYSE:SOLV) by 24.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 19,183 shares of the company’s stock after selling 6,100 shares during the quarter. SG Americas Securities LLC’s holdings in Solventum were worth $1,267,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Modus Advisors LLC purchased a new position in shares of Solventum during the fourth quarter worth approximately $25,000. Copeland Capital Management LLC purchased a new stake in shares of Solventum in the third quarter valued at about $26,000. Mather Group LLC. acquired a new stake in shares of Solventum during the third quarter worth about $27,000. Twin Lakes Capital Management LLC purchased a new position in shares of Solventum during the second quarter worth about $29,000. Finally, True Wealth Design LLC increased its position in Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after acquiring an additional 471 shares during the period.

Wall Street Analysts Forecast Growth

SOLV has been the subject of several recent research reports. Piper Sandler increased their price target on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Stifel Nicolaus began coverage on shares of Solventum in a research note on Tuesday, October 8th. They issued a “buy” rating and a $82.00 target price for the company. Mizuho assumed coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target on the stock. Finally, Morgan Stanley raised their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Solventum has a consensus rating of “Hold” and an average target price of $68.29.

Solventum Price Performance

Solventum stock opened at $75.06 on Tuesday. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The firm’s 50-day simple moving average is $69.56 and its 200 day simple moving average is $66.56. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05.

Solventum (NYSE:SOLV) last issued its quarterly earnings data on Thursday, November 7th. The company reported $1.15 earnings per share for the quarter, missing analysts’ consensus estimates of $1.38 by ($0.23). The firm had revenue of $2.08 billion for the quarter, compared to analyst estimates of $2.05 billion. On average, equities analysts predict that Solventum Co. will post 6.58 EPS for the current year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.